Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Filed Chapter 11
Director departure
Appointed director
Quarterly results
|
|
K-V Pharmaceutical Co (KV.A)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2013 |
8-K
| Appointed a new director|
Docs:
|
"Non-Employee Director Compensation Policy",
"Form of Option Award Agreement",
"Form of Equity Bonus Agreement",
"KV Pharmaceutical Company Appoints Former Wyeth Pharmaceuticals President, Joe Mahady to Chairman of the Board ST. LOUIS, Oct. 3, 2013 – K-V Pharmaceutical Company today announced the appointment of Joseph M. Mahady as Chairman of its Board of Directors. Previously, Mahady served as Senior Vice President of Wyeth, LLC, and President of Wyeth Pharmaceuticals, Inc., where he led the company’s $20 billion global pharmaceutical business. During his tenure, he oversaw the successful launch of more than 30 products in multiple therapeutic areas. Mahady has held various board positions, including Immunex, Albemarle, EKR Therapeutics, Discovery Labs and Cortendo AB. “Joe’s extensive knowledge and expertise in women’s healthcare will play a critical role in establishing a renewed focus at the compa..." |
|
| 08/12/2010 |
8-K
| Appointed a new director |
|
|